Hims & Hers will stop selling some weight-loss drugs — and its stock plummeted
Hims & Hers (HIMS) stock took a steep dive, dropping over 23% in pre-market trading on Tuesday — even after the millennial-focused telehealth company reported soaring sales for 2024 just the night before.Read more...


Hims & Hers (HIMS) stock took a steep dive, dropping over 23% in pre-market trading on Tuesday — even after the millennial-focused telehealth company reported soaring sales for 2024 just the night before.